Medeonföretag

Dianovator

Dianovator AB is a start-up in diabetes technology. They develop a patient-specific decision support system for improved glycemic control by optimized insulin dosing. Their target audience is patients receiving insulin therapy using insulin pens or insulin pumps. Many of these patients experience difficulties optimizing their therapy, resulting in reduced life quality and a shorter life expectancy. Their product can help people achieve a better control, thereby reducing anxiety and lowering the risk of short and long term complications associated with poor glycemic control. Their system relies on established proven sensor technology already available on the market.

ADDRESS
Dianovator AB
Medeon Science Park 
SE- 205 12  Malmö 

CONTACT
Fredrik Ståhl, CEO
Mobile: +46 736 26 18 85
E-mail: fredrik.stahl@dianovator.com

Website: http://www.dianovator.se/

MEDEON IS AN IMPORTANT LIFE SCIENCE NODE WITH ITS CENTRAL LOCATION AND SPECIFIC NETWORKS, OFFERING ONE OF THE ÖRESUND REGION'S BEST GROWTH ENVIRONMENTS FOR COMPANIES. MEDEON PROMOTES INTERCHANGE BETWEEN THE ACADEMIC WORLD, PUBLIC SECTOR AND INDUSTRY.

Catrine Pauckstadt
Communications Manager